NovoCure (NVCR) Change in Inventory (2014 - 2026)

NovoCure (NVCR) has reported Change in Inventory for 13 consecutive years, with -$866000.0 the latest figure, recorded in Q2 2026.

• Quarterly Change in Inventory fell 237.68% year-over-year to -$866000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.0 million (up 496.05% YoY) and the FY2025 annual result came in at $5.7 million, up 320.72% from the prior year.
• Change in Inventory slipped to -$866000.0 in Q2 2026 per NVCR's latest filing, from $2.8 million in the prior quarter.
• Over the last five years, Change in Inventory for NVCR reached as high as $4.8 million in Q1 2022 and fell as low as -$3.4 million in Q4 2024.
• A 5-year average of $1.0 million and a median of $1.1 million in 2023 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory surged 594.74% — and 2024, when it sank 613.45%.
• Year by year, Change in Inventory stood at $2.3 million in 2022, then plunged by 70.67% to $669000.0 in 2023, then plunged by 613.45% to -$3.4 million in 2024, then surged by 157.76% to $2.0 million in 2025, then plunged by 143.65% to -$866000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$866000.0, $2.8 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.